| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3413 | |||||||||||||||||||||||
| Submitter : | Mrs. Dorothy Menke | Date & Time: | 12/18/2006 09:12:36 | |||||||||||||||||||||
| Organization : | Mrs. Dorothy Menke | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
|
I respectfully request Secretary Michael O. Leavitt, Director of HHS to deny permission to pharmaceutical companies to use material from human embryos or aborted human fetuses in the manufacture of vaccines. Please allow only tissue from other sources to be used. Thank you for your consideration of this urgent request. - Dorothy Menke | ||||||||||||||||||||||||